Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020

Aethlon Medical, Inc. (Nasdaq: AEMD) announced it will release its financial results for Q4 FY2020 on June 25, 2020, at 4:15 PM Eastern Time.

Rhea-AI Summary

Aethlon Medical, Inc. (Nasdaq: AEMD) announced it will release its financial results for Q4 FY2020 on June 25, 2020, at 4:15 PM Eastern Time. A conference call is scheduled for the same day at 4:30 PM Eastern, where management will review results and corporate developments, followed by a Q&A session. The Hemopurifier®, Aethlon's immunotherapeutic device, has received FDA's Breakthrough Device designations for cancer and viral infections, aiming to address critical unmet needs in global health.

Positive

• FDA Breakthrough Device designations for Hemopurifier® related to cancer and life-threatening viral infections.

Negative

• None.

Argus Session date unavailable

-2.82% session move Open Argus

Details

News Market Reaction – AEMD

The recorded move for AEMD in the trading session of this news was -2.82%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, June 16, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2020, ended March 31, 2020, at 4:15pm Eastern time on Thursday, June 25, 2020.

Management will host a conference call on Thursday, June 25, 2020 at 4:30pm eastern time to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.

Interested parties can register for the conference by navigating to http://dpregister.com/10145174. Please note that registered participants will receive their dial in number upon registration.

Interested parties without internet access or unable to pre-register may dial in by calling: 

PARTICIPANT DIAL IN (TOLL FREE): 1-844-836-8741
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442
All callers should ask for the Aethlon Medical, Inc. conference call. 

A replay of the call will be available approximately one hour after the end of the call through July 2, 2020. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada Toll Free at 1-855-669-9658. The replay conference ID number is 10145174.

About Aethlon Medical, Inc.

Aethlon Medical is focused on addressing unmet needs in global health.  The Aethlon Hemopurifier® is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier® depletes the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of leading cancer therapies. The Hemopurifier® is an FDA designated "Breakthrough Device" related to the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease cancer. The Hemopurifier also holds a Breakthrough Device designation related to life-threatening viruses that are not addressed with approved therapies.

Additionally, Aethlon owns 80% of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disease progression. Additional information can be found online at www.AethlonMedical.com and www.ExosomeSciences.com.

Company Contact:
Jim Frakes
Chief Financial Officer
Aethlon Medical, Inc. 
858-459-7800 x3300
Jfrakes@aethlonmedical.com

Media Contact:
Tony Russo, Ph.D.
Russo Partners, LLC
tony.russo@russopartnersllc.com
212-845-4251

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com 
212-966-3650

 

View original content:http://www.prnewswire.com/news-releases/aethlon-medical-to-release-fourth-quarter-financial-results-and-host-conference-call-on-june-25-2020-301077496.html

SOURCE Aethlon Medical, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Aethlon Medical announce its fourth quarter financial results for 2020?

Aethlon Medical will announce its fourth quarter financial results for fiscal year 2020 on June 25, 2020, at 4:15 PM Eastern Time.

What time is the conference call for Aethlon Medical's financial results?

The conference call to discuss Aethlon Medical's financial results will be held on June 25, 2020, at 4:30 PM Eastern Time.

What is the Hemopurifier® by Aethlon Medical?

The Hemopurifier® is a clinical-stage immunotherapeutic device designed to combat cancer and viral infections by removing tumor-derived exosomes.

How can I access the replay of Aethlon Medical's conference call?

A replay of Aethlon Medical's conference call will be available approximately one hour after the call and can be accessed through their website or by calling 1-877-344-7529.